Answers are grounded in this paper and cite their sources.
This work reports the synthesis of chiral benzene ligands leading to efficient C–H activation in organic compounds, suggesting improved catalysis methods.
Asymmetric catalysis enabled by a chiral η6-benzene (Ben) metal catalyst is an emerging field with the core challenge lying in the development of effective chiral Ben ligands. This work reports the design and synthesis of a novel class of chiral Ben ligands, namely, binaphthyldimethyl Ben ligands. In this case, a chiral binaphthyl scaffold is linked via a methylene spacer to a benzene ring that serves as the metal-coordination site. Crucially, the Ben ligands coordinate to ruthenium (Ru) in a site-specific manner despite possessing multiple potential η6-benzene binding sites, hence enabling the successful preparation of the targeted chiral BenRuII catalysts. Significantly outperforming our earlier chiral BenRuII catalysts, the system reported herein enables highly efficient phenol-directed asymmetric C–H activation of 1-aryl-2-naphthols with alkynes, providing facile access to diverse chiral spirocyclic compounds featuring an all-carbon quaternary stereocenter in high yields (up to 99%) and with excellent enantioselectivity (up to 97% ee).
No takes yet. Share an insight, caveat, or question.
Mai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: